2017
DOI: 10.1007/s41669-016-0009-9
|View full text |Cite
|
Sign up to set email alerts
|

The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review

Abstract: ObjectiveThe aim of this paper was to review and compare HIV vaccine cost-effectiveness analyses and describe the effects of uncertainty in model, methodology, and parameterization.MethodsWe systematically searched MEDLINE (1985 through May 2016), EMBASE, the Tufts Cost-Effectiveness Analysis (CEA) Registry, and the reference lists of articles following Cochrane and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility criteria included peer-reviewed manuscripts wi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2017
2017
2020
2020

Publication Types

Select...
7
2
1

Relationship

2
8

Authors

Journals

citations
Cited by 22 publications
(23 citation statements)
references
References 37 publications
0
23
0
Order By: Relevance
“…The capital cost accounted for just about one-sixth of the total cost of care 8 26 27 . However, there is a significant variation in capital cost among different hospitals, ranging from 3.4 to 29.3 million, which is associated with scale of operation.…”
Section: Discussionmentioning
confidence: 99%
“…The capital cost accounted for just about one-sixth of the total cost of care 8 26 27 . However, there is a significant variation in capital cost among different hospitals, ranging from 3.4 to 29.3 million, which is associated with scale of operation.…”
Section: Discussionmentioning
confidence: 99%
“…Considerable effort has been expended in trying to stimulate the immune system to counter HIV by using vaccines [30]. A far more reasonable approach is to enhance the ACE pathway.…”
Section: The Ace Pathway Versus the Immune System In Combatting Infecmentioning
confidence: 99%
“…Such vaccine could be seen as a first-generation product that must still be improved upon in order to fundamentally transform the HIV epidemic. Mathematical models [23,19,39,6,18,26,25,16,31,5,24] suggest that the first-generation vaccine would be useful and cost-effective to roll out, but that its overall impact will be modest. Here, we explore what factors contribute collectively to limiting the impact of such a vaccine.…”
Section: Introductionmentioning
confidence: 99%